Literature DB >> 10194953

[Stent restenosis: therapy concepts and possibilities for prevention].

P W Radke1, J vom Dahl, H G Klues.   

Abstract

BACKGROUND: In-stent restenosis has become a significant problem for interventional cardiologists. Due to different pathogenic causes it remains unclear whether a uniform therapeutic regimen is appropriate. TREATMENT: Redilatation has predominantly been used for the treatment of instent restenosis, however, in long and diffuse restenotic stents, long-term results are reported to be poor. Therefore, tissue-debulking techniques may have beneficial effects in complex cases of in-stent restenosis. The therapeutic benefit of intracoronary radiation, local drug delivery or gene transfer has not been evaluated so far. PREVENTION: Therefore, prevention of the iatrogenic entity in-stent restenosis has become more important.

Entities:  

Mesh:

Year:  1999        PMID: 10194953     DOI: 10.1007/bf03044706

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  34 in total

1.  Disruption of a coronary stent during atherectomy for restenosis.

Authors:  R E Bowerman; C A Pinkerton; B Kirk; B F Waller
Journal:  Cathet Cardiovasc Diagn       Date:  1991-12

2.  High-speed rotational ablation for in-stent restenosis.

Authors:  R K Bottner; K R Hardigan
Journal:  Cathet Cardiovasc Diagn       Date:  1997-02

Review 3.  Intravascular local drug delivery after angioplasty.

Authors:  B Höfling; T Y Huehns
Journal:  Eur Heart J       Date:  1995-04       Impact factor: 29.983

Review 4.  Coronary artery stents. American College of Cardiology.

Authors:  C J Pepine; D R Holmes
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

5.  Three-year follow-up after implantation of metallic coronary-artery stents.

Authors:  T Kimura; H Yokoi; Y Nakagawa; T Tamura; S Kaburagi; Y Sawada; Y Sato; H Yokoi; N Hamasaki; H Nosaka
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

6.  Stent wire cutting during coronary directional atherectomy.

Authors:  T Meyer; T Schmidt; A Buchwald; V Wiegand
Journal:  Clin Cardiol       Date:  1993-05       Impact factor: 2.882

Review 7.  Local drug delivery for the prevention of restenosis. Fact, fancy, and future.

Authors:  A M Lincoff; E J Topol; S G Ellis
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

8.  Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

Authors:  J C Tardif; G Cöté; J Lespérance; M Bourassa; J Lambert; S Doucet; L Bilodeau; S Nattel; P de Guise
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

9.  Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment.

Authors:  P C Gordon; C M Gibson; D J Cohen; J P Carrozza; R E Kuntz; D S Baim
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.

Authors:  A J Carter; J R Laird; A Farb; W Kufs; D C Wortham; R Virmani
Journal:  J Am Coll Cardiol       Date:  1994-11-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.